Location History:
- Naperville, IL (US) (2009)
- San Diego, CA (US) (2015 - 2021)
- Irvine, CA (US) (2012 - 2023)
- Carlsbad, CA (US) (2012 - 2024)
Company Filing History:
Years Active: 2009-2025
Title: Richard Chien Yang: A Pioneer in Continuous Glucose Monitoring Technologies
Introduction
Richard Chien Yang is a renowned inventor based in Carlsbad, California, with an impressive portfolio of 32 patents. His work focuses primarily on innovations in medical technology, particularly in the area of continuous glucose monitoring systems, which are pivotal for diabetes management.
Latest Patents
Among his most recent patents is the "Analyte sensor," which provides systems and methods for continuous analyte measurement in a host's vascular system. This innovative glucose measurement system integrates a vascular access device, sensor, and sensor electronics, designed to communicate with the host's circulatory system effectively. Another significant invention is the "Integrated medicament delivery device for use with continuous analyte sensor." This integrated system allows for the monitoring and treatment of diabetes by combining a receiver with a hand-held medicament injection pen. It calculates medicament therapy through continuous glucose sensor data and automatically adjusts bolus doses, significantly improving user experience for diabetes management.
Career Highlights
Richard has made notable contributions while working at Dexcom, Inc., among other organizations. His continuous drive for innovation has led to significant advancements in diabetes care technologies, impacting numerous lives.
Collaborations
Throughout his career, Richard has collaborated with an array of talented individuals, including Apurv Ullas Kamath and Mark C Brister. These collaborations have been instrumental in fostering innovative solutions in the field of medical technology.
Conclusion
Richard Chien Yang's commitment to innovating continuous glucose monitoring systems exemplifies the spirit of modern invention. His contributions are not only critical for technological advancements but also for improving the quality of life for individuals managing diabetes. With his extensive portfolio of patents, Richard continues to influence the future of medical technologies.